viernes, 13 de octubre de 2017

An Aspirin A Day: Maybe Yes, Maybe No - Ivanhoe Broadcast News, Inc.

An Aspirin A Day: Maybe Yes, Maybe No - Ivanhoe Broadcast News, Inc.



Marketing


ORLANDO, Fla. (Ivanhoe Newswire) — Stroke is the fifth leading cause of death in the U.S., but did you know that 80 percent of all strokes are preventable? Here is what you need to do to protect yourself.




RALEIGH, N.C. (Ivanhoe Newswire) — You’ve probably heard that positive thinking will lead to positive outcomes. Now, when it comes to aging, research proves it.




GAINESVILLE, Fla. (Ivanhoe Newswire) — Memory loss, trouble with speech, and mood changes are some of the warning signs of dementia. While most symptoms aren’t noticeable until a person reaches his or her sixties or seventies, scientists say changes in the brain begin decades earlier. Now a specialized prevention program, started at the first signs of cognitive decline, may maximize a person’s quality of life.




GAINESVILLE, Fla. (Ivanhoe Newswire) — Aspirin has been used as a pain reliever for more than 100 years. And since the seventies, popping a pill a day has been doctors’ orders for patients with heart disease. Now, the largest study to date casts some doubt on the benefits of taking an aspirin a day for certain heart patients.




ORLANDO, Fla. (Ivanhoe Newswire) — Everyone wants to know, but only a few ever figure it out. What’s the secret to living a long life? The people in Bapan, China have figured it out. Bapan is known as “longevity village.” It has an average ratio of one centenarian, a person who is 100 years old or older, for every 100 people. In the U.S., that number is one in about 5,000. So, how can you make it to 100? Here are the answers that may get you there.










Quote of the week:

Everybody wants to save the earth; nobody wants to help Mom do the dishes.” 

— P.J. O'Rourke​



Give the gift of health news!
Click here to sign up your friends and loved ones for the 

First to Know Newsletter!


 
 




Website Information: webdoctor@ivanhoe.com

Content Licensing: jcherry@ivanhoe.com

No hay comentarios:

Publicar un comentario